52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

More
Jun 06, 2024
Immutep Limited - Books Closed / Open for Issuance
Jun 02, 2023
Immutep Limited - Books Closed / Open for Issuance

Capital Raising Events

More
DR Price Date DR Price (USD) US/Non-US/Total DRS US/Non-US/Total DR Capital Raised
Jul 05, 2017 1.90 2,631,268
0
2,631,268
4,999,409
0
4,999,409

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Pengana Capital Ltd. 970,608
BlackRock Fund Advisors 740,413
Meridian Wealth Management LLC 394,150
TOP MUTUAL FUND HOLDERS POSITION
Pengana High Conviction Equities Fund 970,608
iShares Biotechnology ETF 655,532
Perinvest (Lux) SICAV - Global Healthcare Equity 25,000

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol IMMP
CUSIP 45257L108
DR Venue NASDAQ Stock Market
DR ISIN US45257L1089
Ratio DR:ORD 1:10
Underlying ISIN AU000000IMM6
Underlying SEDOL 6350516
Country Australia
Effective Date Apr 16, 2012
Depositary BK (Sponsored)
Industry Pharma. & Biotech.
Books Open/Closed Open
Immutep is a development stage biotech company. The Company is engaged in the development of lymphocyte activation gene 3, or LAG-3, a gene linked to the regulation of T cells in immune responses. The Company focuses on the development of immunotherapeutic products for the treatment of cancer and autoimmune diseases. The Company's product candidates under development includes: IMP321, a recombinant protein in clinical trials for the treatment of different types of cancers; IMP761, an agonist antibody of LAG-3; IMP701, an antagonist (blocking) antibody targeting the LAG-3 molecule with potential application in the treatment of cancer; and IMP731, a depleting antibody that removes T cells involved in autoimmunity.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.0500
Cancellation up to $0.0500
Cash Distribution up to $0.0500
Issuance up to $0.0500
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.0500
Rights - Issuance up to $0.0500
Stock Dividend up to $0.0500
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 1.71 1,609,649 76,650
Mar.25 1.76 1,521,569 72,456
Feb.25 1.93 1,308,177 68,851

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE